Evidence map›Paper›PMID 35432299›Full record

ArticleFrontiers in immunology2022

Durable Expansion of TCR-δ Meta-Clonotypes After BCG Revaccination in Humans.

Charlotte A James, Krystle K Q Yu, Koshlan Mayer-Blackwell, Andrew Fiore-Gartland, Malisa T Smith, Erik D Layton, John L Johnson, Willem A Hanekom, Thomas J Scriba, Chetan Seshadri

Open access · goldAbstract readClinical Trial, Phase I
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Role of MHC class I pathways inFrontiers in cellular and infection microbiology · 2023
    Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Charlotte A JamesDepartment of Medicine, University of Washington, Seattle, WA, United States.
Krystle K Q YuDepartment of Medicine, University of Washington, Seattle, WA, United States.
Koshlan Mayer-BlackwellVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States.
Andrew Fiore-GartlandVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States.
Malisa T SmithDepartment of Medicine, University of Washington, Seattle, WA, United States.
Erik D LaytonDepartment of Medicine, University of Washington, Seattle, WA, United States.
John L JohnsonTuberculosis Research Unit, Department of Medicine, Case Western Reserve University and University Hospitals Cleveland Medical Center, Cleveland, OH, United States.
Willem A HanekomSouth African Tuberculosis Vaccine Initiative and Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
Thomas J ScribaSouth African Tuberculosis Vaccine Initiative and Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
Chetan SeshadriDepartment of Medicine, University of Washington, Seattle, WA, United States.
University of Washington · USFred Hutch Cancer Center · USUniversity of Cape Town · ZAUniversity Hospitals of Cleveland · US

Funding

cGMP Manufacture, Fill-Finish, Release, Analytical and Stability Testing and Stability Program of a Nanoparticle Based HIV Envelope Vaccine75N93022D00005 · NIAID · INTERNATIONAL AIDS VACCINE INITIATIVE · PI HASSELL, THOMAS · 2022 to 2025
$8.0M
Task Area A shall encompass annual follow-up of cohort members, clinical events investigations, study operations, and data analysis and manuscript writing. If implemented, Task A.1 will provide fundin75N92020D00005 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI WATSON, KAROL E · 2020 to 2025
$5.1M
Qualification of Assays to Measure Human T-cell Responses Against Mycobacterial Lipid AntigensR01AI125189 · NIAID · UNIVERSITY OF WASHINGTON · PI SESHADRI, CHETAN · 2016 to 2020
$3.1M
NHLBI NIH HHS 75N92020D00005NIAID NIH HHS 75N93022D00005NIAID NIH HHS 75N93023D00005NIAID NIH HHS N01 AI070022NIAID NIH HHS R01 AI125189NIDA NIH HHS 75N95020D00005ORFDO NIH HHS 75N99020D00005
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BCG VaccineMycobacterium tuberculosisAdultChildChild, PreschoolHumansImmunization, SecondaryLeukocytes, MononuclearReceptors, Antigen, T-CellBCG VaccineReceptors, Antigen, T-CellBCG - Bacille Calmette-Guérin vaccinedonor unrestricted T cellsgamma delta (γδ) T cellsiNKT cellMAIT celltuberculosis

Identifiers

PMID35432299
PMCPMC9005636
OpenAlexW4221004309

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.